• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 10, Issue 2
  3. Author

Online ISSN: 2515-8260

Volume10, Issue2

Study on serum uric acid in patients with Metabolic Syndrome at a tertiary care hospital in Tamilnadu

    Jercy Grace, Kalpana B, P Soundara Rajan

European Journal of Molecular & Clinical Medicine, 2023, Volume 10, Issue 2, Pages 1782-1788

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Metabolic Syndrome (MetS) is a set of interrelated clinical disorders, including dyslipidemia, central obesity, glucose intolerance, and high blood pressure. Hyperuricemia is known to cause various inflammatory diseases via uric acid deposition in the joints. Present study was aimed to study serum uric acid in patients with metabolic syndrome at a tertiary care hospital in rural Tamilnadu. Material and Methods: Present study was comparative, observational study, conducted in patients of age > 18 years, either gender, case of metabolic syndrome (cases) & healthy, age & gender matched subjects (controls). Results: In present study 400 cases & age, gender matched 400 controls were participated. We noticed that systolic blood pressure, diastolic blood pressure, fasting blood sugar & triglycerides were significantly higher among patients with metabolic syndrome as compared to controls & difference was statistically significant (p<0.001). While, high-density lipoprotein, total cholesterol & low-density lipoprotein (mg/dL) were comparable in both groups & difference was not significant statistically (p>0.05). In patients with metabolic syndrome higher levels of uric acid (6.78 ± 1.05) were noted as compared to controls (5.16 ± 0.95), difference was statistically significant (p<0.001).In patients of metabolic syndrome higher levels of uric acid were noted in patients with BMI > 30 kg/m2 (6.17 ± 1.02 vs 4.81 ± 0.92), Fasting Blood Sugar ≥100 (6.29 ± 1.09 vs 4.92 ± 0.99), blood Pressure ≥130/85 (6.27 ± 1.13 vs 5.29 ± 1.01) & triglycerides > 150 mg/dL (6.05 ± 0.99 vs 5.53 ± 1.21), difference was statistically significant (p<0.001). Conclusion: Elevated levels of uric acid were seen in patients with metabolic syndrome and also in components of metabolic syndrome such as body mass index, fasting blood sugar, blood pressure & triglycerides
Keywords:
    uric acid metabolic syndrome Body mass index fasting blood sugar Blood Pressure
  • PDF (310 K)
  • XML
(2023). Study on serum uric acid in patients with Metabolic Syndrome at a tertiary care hospital in Tamilnadu. European Journal of Molecular & Clinical Medicine, 10(2), 1782-1788.
Jercy Grace, Kalpana B, P Soundara Rajan. "Study on serum uric acid in patients with Metabolic Syndrome at a tertiary care hospital in Tamilnadu". European Journal of Molecular & Clinical Medicine, 10, 2, 2023, 1782-1788.
(2023). 'Study on serum uric acid in patients with Metabolic Syndrome at a tertiary care hospital in Tamilnadu', European Journal of Molecular & Clinical Medicine, 10(2), pp. 1782-1788.
Study on serum uric acid in patients with Metabolic Syndrome at a tertiary care hospital in Tamilnadu. European Journal of Molecular & Clinical Medicine, 2023; 10(2): 1782-1788.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 16
  • PDF Download: 15
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus